View the ZIFI-200 registration information details.
Back to drug list
ItemsDrug Registration information
ID2903
No2903
Brand NameZIFI-200
IngredientsCEFIXIME TRIHYDRATE EQ.TO ANHYDROUS CEFIXIME 200 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF RESPIRATORY TRACT INFECTIONS, ACUTE OTITIS MEDIA, URINARY TRACT INFECTION, GONOCCOCAL URETHRITIS, TYPHOID AND SEQUENTIAL TREATMENT AFTER INITIAL I.V CHEMOTHERAPY BY PARENTERA CEPHALOSPORIN FOR SEVERE INFECTION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE COLORED, CAPSULE SHAPED, BICONVEX FILM COATED TABLET WITH SCORE LINE ON ONE SIDE AND PLAIN ON OTHER SIDE
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerFDC LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 I 5604/23
FDD Registration Date05/09/2023
Expiry Date04/09/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA